RET and metastatic malignant neoplasm in the lymph nodes: RET mutation involving exons 11 and 16, which are frequently linked to MEN 2A and MEN 2B, respectively, are strongly associated with a higher risk of lymph node metastasis, and particularly the exon 16 mutation has a very aggressive course.